What may happen when CMS vacates the use of the statewide average premium in the risk adjustment transfer formula.
Strategies to accelerate the shift from volume to value
Tomorrow's value will be unlocked once parties synergize incentives.
How pharmaceutical companies can better define, measure, and deliver value to patients.
Edelman's solution-based advice on regaining trust in healthcare and how it got lost in the first place.
We reviewed the approaches State legislators took to offset the effect of defunding CSRs. Here are our observations of activity across the country.
Why a focus on the provider is needed to achieve 4 or 5 Stars.
Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.
Advice on how the healthcare industry can address the pharmaceutical cost problem.
Why are premiums rising amidst the Affordable Care Act market? It's not because of medical trends, says Oliver Wyman's 2018 Carrier Trend Survey.
Adaptability is key for the future healthcare workforce. But those organizations interested in outsourcing their talent need these strategic tools to remain competitive.